Robert Ortega has joined Brain Tunnelgenix Technologies (BTT Corp.) as Chief Technology Officer. He oversees the development of all technology, including cloud, artificial intelligence (AI) and mobile solutions based on the FDA approved Abreu BTT™ 700 System. He also oversees the development of other proprietary and worldwide patented products for noninvasive and continuous brain temperature and thermodynamics monitoring.
“As we create applications that preserve, protect and prolong life, Robert is playing a key role in harnessing the power of cloud computing and the Internet of Things (IOT) to help diminish human suffering,” said Dr. M. Marc Abreu, founder and president of BTT Corp.
Ortega joins BTT Corp. from Microsoft where he served as Principal Enterprise Strategist and Senior Architect to Fortune 100 companies. His focus was to deliver cloud solutions and strategies to achieve digital transformation that helped companies maximize business value by employing Microsoft solutions.
In addition, Ortega led systems architecture at First Union Capital Markets, Wachovia Corporate Investment Bank and Wells Fargo Wholesale Banking. He brings a wealth of knowledge in IT strategic planning, capital markets research and development, prototyping and software application solutions.
While Chief Technology Officer and member of the board of directors at XBond Corp., a financial services technology company, Ortega pioneered software for fixed income trade order management over the Internet.
Ortega is the inventor four U.S. patent applications related to investment banking. He has presented at GlobusWorld on grid computing and service-oriented architecture (SOA) and was featured in Computerworld and InformationWeek.
He graduated from the Executive Development Program at the Kellogg Graduate School of Management at Northwestern University and from the U.S. Coast Guard Academy.
“By combining the power of Brain Thermodynamics, IOT and applied artificial intelligence, we will help individuals and families manage Alzheimer’s disease, Parkinson’s disease, Multiple sclerosis, pregnancy and sleep disorders, as well as improving safety and performance in athletic activities,” said Dr. Abreu.
ABOUT BRAIN TUNNELGENIX TECHNOLOGIES
BTT Corp. is a MedTech company that develops, manufactures and markets solutions based on the brain thermal tunnel with a broad range of applications. The company has over 100 worldwide patents and proprietary products that track brain temperature and thermodynamics in a noninvasive way using the brain thermal tunnel. The company is harnessing the unrivaled power of coupling brain thermodynamics and artificial intelligence to develop subscription services that will help manage and monitor numerous health conditions such as infections, Alzheimer’s disease, Parkinson’s disease, Multiple sclerosis, and other neurological disorders. In 2017, the company will be launching a cloud-based BTT™ Sleep Service to help monitor and manager sleep disorders. Other applications include sports, occupational safety, pregnancy and ovulation detection and hospital use including anesthesia and surgery. BTT Corp. is a member of Microsoft BizSpark Plus, a highly selective program for startup technology firms. The company operates research and engineering facilities in Aventura, Florida, Bridgeport, Connecticut and Sao Paulo, Brazil. For more information, visit http://www.bttcorp.com.
